2010
DOI: 10.1111/j.1742-1241.2006.01039.x
|View full text |Cite
|
Sign up to set email alerts
|

Disabling pansclerotic morphoea: a case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 12 publications
0
5
0
1
Order By: Relevance
“…One novel observation in our cohort is the adult-predominant composition whereas most reported cases are of childhood-onset disease (1, 4, 7-10, 22). The age distribution of patients in the study is not the result of preferential enrollment in the MAC cohort, which is composed of 97 children and 263 adults.…”
Section: Discussionmentioning
confidence: 77%
See 3 more Smart Citations
“…One novel observation in our cohort is the adult-predominant composition whereas most reported cases are of childhood-onset disease (1, 4, 7-10, 22). The age distribution of patients in the study is not the result of preferential enrollment in the MAC cohort, which is composed of 97 children and 263 adults.…”
Section: Discussionmentioning
confidence: 77%
“…Unfortunately, they have not been consistent in how depth of involvement is either defined (ranging from deep dermal to bone) or determined (2, 3, 7, 10-13). We removed this criteria due to ambiguity and instead solely assigned the pansclerotic subtype based on the clinical criteria of rapid evolution of near total body surface area involvement typically spreading centrifugally with sparing the fingers and toes.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Circumscribed morphea can be either superfi cial or deep. Because the superfi cial variant is limited to the epidermis and dermis, it was not included in the present problems, and irreversible functional impairment (6)(7)(8). Musculoskeletal manifestations should be carefully monitored in patients with LS, and the disease should be treated aggressively (9)(10)(11).…”
Section: Clinical Examination Protocolmentioning
confidence: 96%